
Venture capital · Growth stage · Est. 2005
BioStar Capital
BioStar Capital is a US venture capital firm that invests in transformative medical technologies, combining clinicians, healthcare executives and finance professionals in its team and evaluation process.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is BioStar Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds BioStar Capital joined, from press and the firm’s own posts.
1 round in the last 12 months
Round sizes, BioStar Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company BioStar Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet BioStar Capital
Events where BioStar Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
BioStar Capital is based in Charlevoix, United States. It also has an office in Rocky River.
In 2005.
10 fund vehicles are on public registers (SEC adviser filings), including BIOSTAR VENTURES V, L.P., BIOSTAR VENTURES III-XF, LP and BIOSTAR FUND V MMI SPV I, LLC.
Stages: Late stage. Sectors: Medtech, Robotics. From the firm’s own website.
Backs medical technology innovation addressing unmet patient needs, with emphasis on cardiovascular and orthopedics. Proprietary deal flow from healthcare networks is vetted by physician Medical Venture Partners, and the team then helps portfolio companies reach clinical and commercial goals and exit. From the firm’s own website.
BioStar Capital lists 1 portfolio company on its website: Amplitude Vascular Systems (AVS).
Know before BioStar Capital’s next round is announced.
PRO tracks BioStar Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.